<SEC-DOCUMENT>0000905729-25-000142-index.html : 20250813
<SEC-HEADER>0000905729-25-000142.hdr.sgml : 20250813
<ACCEPTANCE-DATETIME>20250813084306
ACCESSION NUMBER:		0000905729-25-000142
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250813
DATE AS OF CHANGE:		20250813

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEOGEN CORP
		CENTRAL INDEX KEY:			0000711377
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				382367843
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-40503
		FILM NUMBER:		251209117

	BUSINESS ADDRESS:	
		STREET 1:		620 LESHER PLACE
		CITY:			LANSING
		STATE:			MI
		ZIP:			48912
		BUSINESS PHONE:		5173729200

	MAIL ADDRESS:	
		STREET 1:		620 LESHER PLACE
		CITY:			LANSING
		STATE:			MI
		ZIP:			48912

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Clarkston Capital Partners, LLC
		CENTRAL INDEX KEY:			0001562855
		ORGANIZATION NAME:           	
		EIN:				830473650
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		303 E. THIRD STREET
		STREET 2:		SUITE 110
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-723-8000

	MAIL ADDRESS:	
		STREET 1:		303 E. THIRD STREET
		STREET 2:		SUITE 110
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Clarkston Capital Partners LLC
		DATE OF NAME CHANGE:	20121126
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ccp13gneogenex991.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: ccp13gneogenex991.htm

</DOCUMENT>
</SEC-DOCUMENT>